|
India, China to Top API Supply Heap Despite Rising Costs, Analysts Say
Despite increasing costs and a shaky quality record, India and China will continue for now to supply active pharmaceutical ingredients (API) at a steady clip, outpacing other foreign suppliers, industry analysts predict.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives